This designation is meaningful as it signifies our continued commitment to making biosimilars more accessible. Both biosimilars and interchangeable biosimilars are highly similar and have no ...

Myasthenia gravis is an autoimmune disorder in which antibodies disrupt the communication between nerves and muscles, ...

YUFLYMA® (adalimumab-aaty) is a high-concentration (100mg/mL) and citrate-free formulation of Humira® (adalimumab) biosimilar ...

HADLIMA™ (adalimumab-bwwd) injection, 40 mg/0.4 mL & 40 mg/0.8 mL is now interchangeable with all high- and low-concentration presentations ...

Discover how Mediterranean strawberry tree extract shows promise for treating ulcerative colitis with fewer side effects than drugs.

The FDA has approved Johnson & Johnson's anti-FcRn antibody, nipocalimab, for the treatment of generalized myasthenia gravis. The drug will be sold under the brand name IMAAVY. This approval ...

Results of the updated systematic review informing the 2024 EULAR recommendations showed that many ARDs are safe to use during pregnancy, lactation, and reproduction.

The British Society for Rheumatology has moved toward a life course approach when updating guidelines for several rheumatic ...

The drug, called trontinemab, showed in the study that it could achieve rapid and deep reductions in amyloid beta plaques in the brain, one of the characteristics of Alzheimer's. Roche said its ...

Need to identify a tablet or capsule? Use our Pill Identifier to find the name and image of an unknown prescription or over-the-counter medication. Start by entering details like pill imprint code ...

After rejecting ImmunityBio’s Anktiva last year, the FDA has cleared the drug as a treatment for bladder cancer, making it the company’s first commercial-stage product. Anktiva (nogapendekin ...

Helping you find the right treatment for your pet's needs. NexGard: NexGard Products for Fleas, Ticks, and Heartworms in Dogs and Cats Simparica: Simparica Products for Fleas, Ticks, & Heartworms ...